Signaturefd, LLC Axonics, Inc. Transaction History

Signaturefd, LLC

$5.2 Billion
Q3 2024

A detailed history of Signaturefd, LLC transactions in Axonics, Inc. stock. As of the latest transaction made, Signaturefd, LLC holds 203 shares of AXNX stock, worth $14,408. This represents 0.0% of its overall portfolio holdings.

Number of Shares

203

Previous 203 -0.0%

Holding current value

$14,408

Previous $13,000 7.69%

% of portfolio

0.0%

Previous 0.0%

15 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Jul 29, 2024	SELL	$66.47 - $69.65 $1,861 - $1,950	-28 Reduced 12.12%	203 $13,000
Q4 2023 Jan 31, 2024	SELL	$49.38 - $63.75 $2,864 - $3,697	-58 Reduced 20.07%	231 $14,000
Q3 2023 Nov 03, 2023	BUY	$48.64 - $62.51 $4,231 - $5,438	87 Added 43.07%	289 $16,000
Q2 2023 Aug 01, 2023	SELL	$47.99 - $60.21 $9,070 - $11,379	-189 Reduced 48.34%	202 $10,000
Q1 2023 Apr 28, 2023	SELL	$52.6 - $67.34 $14,307 - $18,316	-272 Reduced 41.03%	391 $21,000
Q4 2022 Jan 27, 2023	BUY	$59.56 - $76.6 $8,219 - $10,570	138 Added 26.29%	663 $41,000
Q3 2022 Nov 08, 2022	BUY	$57.96 - $78.12 $753 - $1,015	13 Added 2.54%	525 $37,000
Q2 2022 Aug 10, 2022	BUY	$39.5 - $64.42 $2,409 - $3,929	61 Added 13.53%	512 $29,000
Q1 2022 May 02, 2022	BUY	$43.74 - $62.76 $15,790 - $22,656	361 Added 401.11%	451 $28,000
Q4 2021 Jan 25, 2022	BUY	$50.01 - $73.35 $250 - $366	5 Added 5.88%	90 $5,000
Q3 2021 Oct 28, 2021	BUY	$59.21 - $78.66 $592 - $786	10 Added 13.33%	85 $6,000
Q2 2021 Jul 26, 2021	BUY	$51.39 - $66.9 $411 - $535	8 Added 11.94%	75 $5,000
Q1 2021 Apr 30, 2021	BUY	$49.14 - $59.89 $933 - $1,137	19 Added 39.58%	67 $4,000
Q4 2020 Feb 11, 2021	SELL	$42.19 - $51.5 $759 - $927	-18 Reduced 27.27%	48 $2,000
Q3 2020 Nov 03, 2020	BUY	$35.33 - $51.04 $2,331 - $3,368	66 New	66 $3,000

Others Institutions Holding AXNX

# of Institutions

235

Shares Held

42.1M

Call Options Held

83.4K

Put Options Held

65.3K

View Full List

About Axonics, Inc.

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

More about AXNX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Signaturefd, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Signaturefd, LLC with notifications on news.

Account